Evidence map›Paper›PMID 27242772›Full record

ArticleFrontiers in microbiology2016

Synergistic and Additive Effect of Oregano Essential Oil and Biological Silver Nanoparticles against Multidrug-Resistant Bacterial Strains.

Sara Scandorieiro, Larissa C de Camargo, Cesar A C Lancheros, Sueli F Yamada-Ogatta, Celso V Nakamura, Admilton G de Oliveira, Célia G T J Andrade, Nelson Duran, Gerson Nakazato, Renata K T Kobayashi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
14.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. A Novel Ag/AgCl/AgMicroorganisms · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Nail Lacquer ContainingAntibiotics (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Green Synthesis of Silver Nanoparticle fromAntibiotics (Basel, Switzerland) · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sara ScandorieiroLaboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Larissa C de CamargoLaboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Cesar A C LancherosLaboratory of Molecular Biology of Microorganisms, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Sueli F Yamada-OgattaLaboratory of Molecular Biology of Microorganisms, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Celso V NakamuraLaboratory of Technological Innovation in Drug and Cosmetics Development, Department of Basic Health Sciences, Center of Health Sciences, Universidade Estadual de Maringá Maringá, Brazil.
Admilton G de OliveiraLaboratory of Microbial Ecology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Célia G T J AndradeLaboratory of Electron Microscopy and Microanalysis, Department of General Biology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Nelson DuranInstitute of Chemistry, Universidade Estadual de Campinas Campinas, Brazil.
Gerson NakazatoLaboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Renata K T KobayashiLaboratory of Basic and Applied Bacteriology, Department of Microbiology, Center of Biological Sciences, Universidade Estadual de Londrina Londrina, Brazil.
Universidade Estadual de Londrina · BRUniversidade Estadual de Campinas (UNICAMP) · BRUniversidade Estadual de Maringá · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial resistance to conventional antibiotics has become a clinical and public health problem, making therapeutic decisions more challenging. Plant compounds and nanodrugs have been proposed as potential antimicrobial alternatives. Studies have shown that oregano (Origanum vulgare) essential oil (OEO) and silver nanoparticles have potent antibacterial activity, also against multidrug-resistant strains; however, the strong organoleptic characteristics of OEO and the development of resistance to these metal nanoparticles can limit their use. This study evaluated the antibacterial effect of a two-drug combination of biologically synthesized silver nanoparticles (bio-AgNP), produced by Fusarium oxysporum, and OEO against Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. OEO and bio-AgNP showed bactericidal effects against all 17 strains tested, with minimal inhibitory concentrations (MIC) ranging from 0.298 to 1.193 mg/mL and 62.5 to 250 μM, respectively. Time-kill curves indicated that OEO acted rapidly (within 10 min), while the metallic nanoparticles took 4 h to kill Gram-negative bacteria and 24 h to kill Gram-positive bacteria. The combination of the two compounds resulted in a synergistic or additive effect, reducing their MIC values and reducing the time of action compared to bio-AgNP used alone, i.e., 20 min for Gram-negative bacteria and 7 h for Gram-positive bacteria. Scanning electron microscopy (SEM) revealed similar morphological alterations in Staphylococcus aureus (non-methicillin-resistant S. aureus, non-MRSA) cells exposed to three different treatments (OEO, bio-AgNP and combination of the two), which appeared cell surface blebbing. Individual and combined treatments showed reduction in cell density and decrease in exopolysaccharide matrix compared to untreated bacterial cells. It indicated that this composition have an antimicrobial activity against S. aureus by disrupting cells. Both compounds showed very low hemolytic activity, especially at MIC levels. This study describes for the first time the synergistic and additive interaction between OEO and bio-AgNP produced by F. oxysporum against multidrug-resistant bacteria, such as MRSA, and β-lactamase- and carbapenemase-producing Escherichia coli and Acinetobacter baumannii strains. These results indicated that this combination can be an alternative in the control of infections with few or no treatment options.

Indexed as

antibacterialbiological silver nanoparticlesmultidrug-resistant bacteriaoregano oilsynergism

Identifiers

PMID27242772
PMCPMC4876125
OpenAlexW2408686918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.